Maintenance of wakefulness test: how does it predict accident risk in patients with sleep disorders?


Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
01 2021
Historique:
received: 09 03 2020
revised: 09 04 2020
accepted: 10 04 2020
pubmed: 12 8 2020
medline: 22 6 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

To determine whether the objective level of alertness measured by the Maintenance of Wakefulness Test (MWT) is associated with the occurrence of self-reported sleepiness-related traffic near misses and accidents related to sleepiness in patients with sleep disorders. This case-control study was conducted over a three-year period in four French sleep centers during a 4∗40 min MWT in patients driving more than 5000 Km/year. Relationship between mean sleep latency on the MWT (MWT latency) and age, sex, driving, sleepiness-related near misses and accidents reported during the previous year, and sleep disorder characteristics was analyzed. Of 377 patients suffering from OSAS, idiopathic hypersomnia, narcolepsy, restless leg syndrome or insufficient sleep syndrome, 176 were included. 74 cases reported an accident or near miss related to sleepiness at the wheel in the past year, and 102 reported no accident/near miss (control patients). Thirty-one (37.8 %) cases and 9 (8.8 %) controls reported being sleepy at the wheel more than once a week (p < 0.0001). After adjusted regression analyses, patients with MWT latency between 19 and 33 minutes had a 3.2- (CI 95%[1.5; 6.8], p < 0.0001) fold increase in risk of reporting a near miss/ accident and patients with MWT latency <19 min had a 5.5- (CI 95%[2.2; 13.8], p = 0.003) fold increase in this risk, compared to the referent group (MWT latency>33 min). MWT latency is associated with self-reported, sleepiness-related near misses and accidents related to sleepiness in the past year in patients routinely investigated in sleep clinics. The MWT could be used to assess driving risk together with clinical interviews assessing sleepiness at the wheel.

Identifiants

pubmed: 32778442
pii: S1389-9457(20)30168-4
doi: 10.1016/j.sleep.2020.04.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-255

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Pierre Philip (P)

Université de Bordeaux, Sommeil, Addiction et Neuropsychiatrie, USR 3413, Bordeaux, France; CNRS, SANPSY, USR 3413, Bordeaux, France; CHU Bordeaux, Centre Hypersomnies Rares, Bordeaux, France. Electronic address: pr.philip@free.fr.

Kelly Guichard (K)

Université de Bordeaux, Sommeil, Addiction et Neuropsychiatrie, USR 3413, Bordeaux, France; CNRS, SANPSY, USR 3413, Bordeaux, France; CHU Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Mélanie Strauss (M)

Neuropsychology and Functional Imaging Research Group, Center for Research in Cognition and Neurosciences, Université Libre de Bruxelles, Brussels, Belgium; Department of Neurology and Psychiatry, Erasme Hospital, Cliniques Universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium; Université de Paris, VIFASOM (Vigilance, Fatigue, Sommeil et Santé Publique), EA 7330, Paris, France; APHP, Hôtel-Dieu de Paris, Centre du Sommeil et de la Vigilance, France.

Damien Léger (D)

Université de Paris, VIFASOM (Vigilance, Fatigue, Sommeil et Santé Publique), EA 7330, Paris, France; APHP, Hôtel-Dieu de Paris, Centre du Sommeil et de la Vigilance, France.

Emilie Pepin (E)

Université de Paris, VIFASOM (Vigilance, Fatigue, Sommeil et Santé Publique), EA 7330, Paris, France; APHP, Hôtel-Dieu de Paris, Centre du Sommeil et de la Vigilance, France.

Isabelle Arnulf (I)

Sleep Disorder Unit, Pitié-Salpêtrière University Hospital (APHP), Paris, France.

Patricia Sagaspe (P)

Université de Bordeaux, Sommeil, Addiction et Neuropsychiatrie, USR 3413, Bordeaux, France; CNRS, SANPSY, USR 3413, Bordeaux, France; CHU Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Lucie Barateau (L)

Reference National Center for Narcolepsy, Sleep Unit, CHU Montpellier, Montpellier, France; PSNREC, Univ Montpellier, INSERM, Montpellier, France.

Régis Lopez (R)

Reference National Center for Narcolepsy, Sleep Unit, CHU Montpellier, Montpellier, France; PSNREC, Univ Montpellier, INSERM, Montpellier, France.

Jacques Taillard (J)

Université de Bordeaux, Sommeil, Addiction et Neuropsychiatrie, USR 3413, Bordeaux, France; CNRS, SANPSY, USR 3413, Bordeaux, France; CHU Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Jean-Arthur Micoulaud-Franchi (JA)

Université de Bordeaux, Sommeil, Addiction et Neuropsychiatrie, USR 3413, Bordeaux, France; CNRS, SANPSY, USR 3413, Bordeaux, France; CHU Bordeaux, Centre Hypersomnies Rares, Bordeaux, France.

Yves Dauvilliers (Y)

Reference National Center for Narcolepsy, Sleep Unit, CHU Montpellier, Montpellier, France; PSNREC, Univ Montpellier, INSERM, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH